FDA Approves Second Lab-Grown Chicken Product for Commercialization in the US

GOOD Meat has become the second startup to receive a 'no questions' letter from the US Food and Drug Administration (FDA) for its process of growing chicken from cells outside of the animal. The company plans to produce cultivated chicken products for the US market later this year from a 3,500-liter bioreactor in Alameda, California, pending approval from the US Dept of Agriculture (USDA). The FDA regulates cell collection, banking, growth, and differentiation for cultivated meat and poultry, while regulatory oversight switches to the USDA once the cells are harvested and through the processing and labeling stages.